Search Results Search Sort by RelevanceMost Recent Case and Commentary Sep 2023 What Makes Palliative Mental Health Care Ethical Health Care? Virginia A. Brown, PhD, MA and Ashley Trust, MD Treatment-resistant schizophrenia can create a high disease burden for some patients, making it hard to get good outcomes. AMA J Ethics. 2023;25(9):E674-677. doi: 10.1001/amajethics.2023.674. Medicine and Society Jun 2024 How to Mitigate Community Harms of Antibacterial Resistance With Patient-Centered Care Chelsea Modlin, MD Merits of more antimicrobial prescription oversight should be weighed against risks to patients and communities of untreatable bacterial infections. AMA J Ethics. 2024;26(6):E494-501. doi: 10.1001/amajethics.2024.494. Medicine and Society Jun 2024 How Should Focus Be Shifted From Individual Preference to Collective Wisdom for Patients at the End of Life With Antimicrobial-Resistant Infections? Jeannie P. Cimiotti, PhD, RN, Kimberly Adams Tufts, ND, WHNP-BC, Lucia D. Wocial, PhD, RN, HEC-C, and Elizabeth Peter, PhD, RN Some patients’ end-of-life care plans still require good antimicrobial management. AMA J Ethics. 2024;26(6):E486-493. doi: 10.1001/amajethics.2024.486. Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551. Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
Case and Commentary Sep 2023 What Makes Palliative Mental Health Care Ethical Health Care? Virginia A. Brown, PhD, MA and Ashley Trust, MD Treatment-resistant schizophrenia can create a high disease burden for some patients, making it hard to get good outcomes. AMA J Ethics. 2023;25(9):E674-677. doi: 10.1001/amajethics.2023.674.
Medicine and Society Jun 2024 How to Mitigate Community Harms of Antibacterial Resistance With Patient-Centered Care Chelsea Modlin, MD Merits of more antimicrobial prescription oversight should be weighed against risks to patients and communities of untreatable bacterial infections. AMA J Ethics. 2024;26(6):E494-501. doi: 10.1001/amajethics.2024.494.
Medicine and Society Jun 2024 How Should Focus Be Shifted From Individual Preference to Collective Wisdom for Patients at the End of Life With Antimicrobial-Resistant Infections? Jeannie P. Cimiotti, PhD, RN, Kimberly Adams Tufts, ND, WHNP-BC, Lucia D. Wocial, PhD, RN, HEC-C, and Elizabeth Peter, PhD, RN Some patients’ end-of-life care plans still require good antimicrobial management. AMA J Ethics. 2024;26(6):E486-493. doi: 10.1001/amajethics.2024.486.
Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551.
Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512.